CLINICAL_TRIALS
trial_result
· 2025-07-24
Clinical Trial Update: A Study of JR-141 in Patients With Mucopolysaccharidosis II (BR21) [Phase 2]
Summary
A Phase 2 study evaluating JR-141 in patients with mucopolysaccharidosis II has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: JCR Pharmaceuticals Co., Ltd. | Conditions: Mucopolysaccharidosis II | Phase 2 | Status: COMPLETED